Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Illumina, Inc. ILMN

Healthcare  —  Diagnostics & Research
270.00 (3.90) (1.42%) as of 25 Sep
Market cap
$41.3B
P/E
50.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Illumina, Inc. (ILMN) EV/EBITDA

As of 25 September 2026, Illumina, Inc. (ILMN) trades at a EV/EBITDA of 36.0×. Over the past ten years it has ranged from 0.0× (June 2025) to 389× (January 2022); the current reading is higher than 58% of that period. That is above the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 18.8× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 350× 457.37%
FY2020 62.7× 69.13%
FY2019 37.1× (1.13%)
FY2018 37.5× (3.75%)
FY2017 39.0× 61.86%
FY2016 24.1× (29.96%)

Quarterly

Period EV/EBITDA Change
Jun 2026 23.3× 35.84%
Mar 2026 17.2× (8.71%)
Dec 2025 18.8× 38.43%
Sep 2025 13.6× 38.70%
42 more quarters

Against its own ten years

Low 0.0× High 389×
Ten-year median 33.3×
Current reading's percentile 58

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
IQV IQVIA Holdings Inc. compare 17.3×
MTD Mettler-Toledo International, Inc. compare 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
A Agilent Technologies, Inc. compare 26.5×
ILMN Illumina, Inc. 36.0×
WAT Waters Corporation compare 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ILMN